Published in J Viral Hepat on September 01, 2005
S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model. Hepatology (2009) 1.32
Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice. Am J Pathol (2010) 1.06
Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study. Hippokratia (2011) 0.88
Epidemiological Aspects of Hepatitis B and C and Human Immunodeficiency Viruses Among Hemodialysis Patients in Mazandaran Province, Iran. Nephrourol Mon (2016) 0.83
Reasons for compliance or noncompliance with advice to test for hepatitis C via an internet-mediated blood screening service: a qualitative study. BMC Public Health (2011) 0.79
Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study. Hippokratia (2014) 0.75
Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin. Pharmgenomics Pers Med (2010) 0.75
Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma. World J Surg (2008) 0.75
Confounding and effect modification in the short-term effects of ambient particles on total mortality: results from 29 European cities within the APHEA2 project. Epidemiology (2001) 5.80
Methodological issues in studies of air pollution and daily counts of deaths or hospital admissions. J Epidemiol Community Health (1996) 4.44
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
Short term effects of air pollution on health: a European approach using epidemiologic time series data: the APHEA protocol. J Epidemiol Community Health (1996) 3.90
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50
Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Air Pollution and Health: a European Approach. Am J Respir Crit Care Med (2001) 3.40
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74
Evidence for interaction between air pollution and high temperature in the causation of excess mortality. Arch Environ Health (1993) 2.67
Time-series analysis of air pollution and cause-specific mortality. Epidemiology (1998) 2.60
Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J (1997) 2.43
HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill (2011) 2.42
Urban air pollution and emergency admissions for asthma in four European cities: the APHEA Project. Thorax (1997) 2.31
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22
Short-term effects of nitrogen dioxide on mortality: an analysis within the APHEA project. Eur Respir J (2006) 2.00
Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill (2009) 1.98
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med (1991) 1.91
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther (2005) 1.86
Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV. J Med Virol (1999) 1.77
Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B. Hepatology (2000) 1.66
Short-term effects of air pollution on mortality in Athens. Int J Epidemiol (1986) 1.61
Short-term effects of air pollution on hospital admissions of respiratory diseases in Europe: a quantitative summary of APHEA study results. Air Pollution and Health: a European Approach. Arch Environ Health (1998) 1.59
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol (2003) 1.53
Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology (1987) 1.44
Increased liver decompensation risk with atypical hepatitis C virus antibody levels. J Infect Dis (2000) 1.41
Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus. J Hepatol (1994) 1.40
Attitudes of a Mediterranean population to the truth-telling issue. J Med Ethics (1992) 1.39
De novo autoimmune hepatitis associated with PTH(1-34) and PTH(1-84) administration for severe osteoporosis in a liver transplant patient. Osteoporos Int (2011) 1.39
The 1987 Athens heatwave. Lancet (1988) 1.39
Air pollution and cause specific mortality in Athens. J Epidemiol Community Health (1990) 1.38
A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction (1998) 1.30
Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology (1991) 1.29
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis (1999) 1.27
School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modeling study. Euro Surveill (2009) 1.24
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat (2015) 1.22
Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. J Virol Methods (2002) 1.20
Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA (1991) 1.20
Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates. Arch Virol (1992) 1.18
Detection of hepatitis A virus by extraction of viral RNA and molecular hybridization. J Clin Microbiol (1987) 1.18
Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer (1996) 1.18
Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease. Gut (1981) 1.17
Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs. J Infect Dis (1988) 1.15
Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet (2000) 1.13
The temporal pattern of mortality responses to ambient ozone in the APHEA project. J Epidemiol Community Health (2009) 1.13
Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM (2000) 1.12
The validity of gynecological ultrasonography. Gynecol Obstet Invest (1990) 1.12
Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia. Lancet (1978) 1.12
Short-term effects of ambient particles on mortality in the elderly: results from 28 cities in the APHEA2 project. Eur Respir J Suppl (2003) 1.12
The role of computerized tomography in the diagnosis and therapy of parotid stones: a case report. J Am Dent Assoc (2000) 1.11
Chronic pancreatitis, sclerosing cholangitis, and sicca complex in two siblings. Lancet (1975) 1.10
Investigating the dose-response relation between air pollution and total mortality in the APHEA-2 multicity project. Occup Environ Med (2003) 1.10
Investigating regional differences in short-term effects of air pollution on daily mortality in the APHEA project: a sensitivity analysis for controlling long-term trends and seasonality. Environ Health Perspect (2001) 1.10
Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat (2006) 1.08
The clinical presentation of Von Meyenburg complexes. Hippokratia (2011) 1.08
Effects of lead on the somatic growth of children. Arch Environ Health (1998) 1.06
Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine. Aliment Pharmacol Ther (2007) 1.06
Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics (1998) 1.04
Desmoid tumor presenting as intra-abdominal abscess. Dig Dis Sci (2006) 1.04
Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection. Ann Rheum Dis (2010) 1.03
Endemic Kaposi's sarcoma in human immunodeficiency virus type 1-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol (1990) 1.03
Antibodies to a human liver membrane lipoprotein (LSP) in primary biliary cirrhosis. Gut (1980) 1.03
Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece. Eur J Epidemiol (1996) 1.02
A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect (2008) 1.02
Fulminant hepatitis due to Epstein-Barr virus infection. J Hepatol (1995) 1.02
High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review. Am J Transplant (2012) 1.02
Clinical predictors of poor outcomes among patients with nonvariceal upper gastrointestinal bleeding in Europe. Aliment Pharmacol Ther (2011) 1.01
Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study. Aliment Pharmacol Ther (2009) 0.99
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation. Transpl Infect Dis (2012) 0.98
Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection. J Infect Dis (2001) 0.98
Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis. J Hepatol (1995) 0.98
Passive smoking and chronic obstructive lung disease. Lancet (1987) 0.97
HIV epidemiology in Greece. Future Microbiol (2008) 0.96
The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha-2b plus ribavirin treatment of naive and nonresponder chronic hepatitis C patients. J Viral Hepat (2005) 0.96
Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort Study. AIDS (1998) 0.96
Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon-alpha and ribavirin. J Viral Hepat (2013) 0.96
Review article: novel therapeutic options for chronic hepatitis C. Aliment Pharmacol Ther (2008) 0.96
The epidemiologic profile of Kaposi's sarcoma in Greece prior to and during the AIDS era. Int J Cancer (1997) 0.95
Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA (1992) 0.95
Searching for West Nile virus (WNV) in Greece. Transfus Med (2009) 0.95
Quantitative detection of the M204V hepatitis B virus minor variants by amplification refractory mutation system real-time PCR combined with molecular beacon technology. J Clin Microbiol (2009) 0.95
Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees. Eur J Epidemiol (2001) 0.94
Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat (2010) 0.94